Migraine


Migraine is a common disabling brain disorder. Headache accounts for 4.4% of all consultations in general practice approximately 7% of all medical admissions to hospital and approximately 25% of neurology outpatient consultations. Migraine affects over 20% of people at some point in their lives; epidemiological studies have shown that 4.6% of the population of Western Europe has headache on at least 15 days per month global studies suggest that approximately 2% of the world’s population may have chronic migraine. Chronic migraine imposes a substantial economic burden on society

 

    Related Conference of Migraine

    March 14-15, 2024

    36th World Conference on Neurology

    Paris, France
    March 18-19, 2024

    28th International Conference on Neurology & Neurophysiology

    Zurich, Switzerland
    April 11-12, 2024

    36th World Neuroscience and Neurology Conferences

    Amsterdam, Netherlands
    April 11-12, 2024

    38th European Neurology Congress

    Amsterdam, Netherlands
    April 11-12, 2024

    36th World Congress on Neurorehabilitation

    Amsterdam, Netherlands
    May 30-31, 2024

    2nd International conference on Neuro Surgery

    Vienna, Austria
    June 13-14, 2024

    37th European Neurology Congress 2024

    Rome, Italy
    June 27-28, 2024

    2nd International conference on Dementia

    London, UK
    June 27-28, 2024

    6th World Depression Congress

    Paris, France
    July 11-12, 2024

    4th Annual Dementia Congress

    Vancouver, Canada
    July 15-16, 2024

    7th World Conference on Neuroscience

    London, UK
    August 13-14, 2024

    14th Global Alzheimers Summit

    Amsterdam, Netherlands
    August 16-17, 2024

    30th Annual Summit on Neuroscience & Neurological Disorders

    Melbourne, Australia
    October 31-01, 2024

    7th Global Congress on Spine and Spinal Disorders

    Amsterdam, Netherlands

    Migraine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in